BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20019695)

  • 61. [Genetic performance criteria for valproate in patients with epilepsy].
    Oros MM
    Lik Sprava; 2011; (3-4):113-9. PubMed ID: 22416375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT
    Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment.
    De Mattia E; Toffoli G; Polesel J; D'Andrea M; Corona G; Zagonel V; Buonadonna A; Dreussi E; Cecchin E
    Pharmacogenet Genomics; 2013 Oct; 23(10):549-57. PubMed ID: 24018773
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
    Herranz JL
    Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular diagnosis of ATP-binding cassette transporter-related diseases.
    Schuierer MM; Langmann T
    Expert Rev Mol Diagn; 2005 Sep; 5(5):755-67. PubMed ID: 16149878
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy.
    Ieiri I; Takane H; Hirota T; Otsubo K; Higuchi S
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):651-74. PubMed ID: 17014387
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Mechanisms of drug resistance in epilepsy].
    Lasoń W
    Przegl Lek; 2006; 63(11):1218-20. PubMed ID: 17348420
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymorphic variants of the multidrug resistance gene Mdr1a and response to antiepileptic drug treatment in the kindling model of epilepsy.
    Baars C; Löscher W; Leeb T; Becker A; Potschka H
    Eur J Pharmacol; 2006 Nov; 550(1-3):54-61. PubMed ID: 17045987
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
    Pati S; Alexopoulos AV
    Cleve Clin J Med; 2010 Jul; 77(7):457-67. PubMed ID: 20601619
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse drug reactions in veterinary patients associated with drug transporters.
    Mealey KL
    Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1067-78. PubMed ID: 23890239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structural basis for the mechanism of ABC transporters.
    Beis K
    Biochem Soc Trans; 2015 Oct; 43(5):889-93. PubMed ID: 26517899
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug resistance in epilepsy: why is a simple explanation not enough?
    Löscher W; Sills GJ
    Epilepsia; 2007 Dec; 48(12):2370-2. PubMed ID: 18088269
    [No Abstract]   [Full Text] [Related]  

  • 73. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The clinical impact of pharmacogenetics on the treatment of epilepsy.
    Löscher W; Klotz U; Zimprich F; Schmidt D
    Epilepsia; 2009 Jan; 50(1):1-23. PubMed ID: 18627414
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiepileptic medication during pregnancy: does fetal genotype affect outcome?
    Atkinson DE; Brice-Bennett S; D'Souza SW
    Pediatr Res; 2007 Aug; 62(2):120-7. PubMed ID: 17597651
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transporters in drug-refractory epilepsy: clinical significance.
    Marchi N; Gonzalez-Martinez J; Nguyen MT; Granata T; Janigro D
    Clin Pharmacol Ther; 2010 Jan; 87(1):13-5. PubMed ID: 20019694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature).
    Smolarz B; Makowska M; Romanowicz H
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The 24th International Symposium of Sapporo Cancer Seminar "Pharmacogenomics in Cancer Chemotherapy: Recent Advances in ABC Transporters and Genome Analyses". Hokkaido University Conference Hall, Sapporo, Japan, June 20-22, 2004.
    Ishikawa T
    J Exp Ther Oncol; 2004 Oct; 4(3):253-7. PubMed ID: 15724845
    [No Abstract]   [Full Text] [Related]  

  • 80. Genetics of epilepsy: epilepsy research foundation workshop report.
    Sisodiya S; Cross JH; Blümcke I; Chadwick D; Craig J; Crino PB; Debenham P; Delanty N; Elmslie F; Gardiner M; Golden J; Goldstein D; Greenberg DA; Guerrini R; Hanna M; Harris J; Harrison P; Johnson MR; Kirov G; Kullman DM; Makoff A; Marini C; Nabbout R; Nashef L; Noebels JL; Ottman R; Pirmohamed M; Pitkänen A; Scheffer I; Shorvon S; Sills G; Wood N; Zuberi S
    Epileptic Disord; 2007 Jun; 9(2):194-236. PubMed ID: 17525034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.